Variables | Category | DRPs | COR (95% CI) | AOR (95% CI) | P-value | |
---|---|---|---|---|---|---|
No (n = 134) | Yes (n = 164) | |||||
Age | 18–30 | 82 (61.19%) | 100 (60.98%) | 1 | 1 | 0.08 |
31–60 | 44 (32.84%) | 50 (30.49%) | 0.932(0.57–1.54) | 1.475 (0.796–2.73) | 0.22 | |
> 60 | 8 (5.97) | 14(8.54%) | 1.44(0.57–3.59) | 0.274 (.066–1.14) | 0.074 | |
Sex | Female | 31 (23.13%) | 95 (57.93%) | 4.575(2.755–7.59) | 3.57 (1.85–6.88) | < 0.001 |
Male | 103 (76.87%) | 69 (42.07%) | 1 | 1 | ||
Residency | Urban | 43 (32.09%) | 82 (50%) | 2.116(1.317–3.40) | 1.09 (0.60–1.98) | 0.78 |
Rural | 91 (67.91%) | 82 (50%) | 1 | 10.762 (0.395–1.47) | ||
Frequency of seizure | ≤ 3 | 79 (58.96%) | 81 (49.39%) | 1 | 1 | 0.004 |
> 4 | 55 (41.04%) | 83 (50.71%) | 1.47 (0.93–2.33) | 2.474 (1.329–4.61) | ||
Family history | No | 77 (57.46%) | 117 (71.34%) | 1 | 1 | 0.24 |
Yes | 57 (42.54%) | 47 (28.66%) | 1.843 (1.14–2.98) | 1.477 (0.775–2.81) | ||
Poly-pharmacy | No | 114 (85.07%) | 114 (69.51%) | 1 | 1 | 0.004 |
Yes | 20 (14.93%) | 50 (30.49%) | 2.50(1.4–4.47) | 3.57 (1.496–8.5) | ||
Presence of comorbidity | No | 89 (66.42%) | 117 (71.34%) | 1 | 1 | 0.36 |
Yes | 45 (33.58%) | 47 (28.66%) | 1.26(0.769–2.06) | 1.21 (0.93–3.41) |